Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 3

2(28.6%)

Phase 4

2(28.6%)

7Total

N/A(3)

Phase 3(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06733168Not ApplicableRecruiting

The Impact of PEEP-guided Electrical Impedance Tomography on Oxygenation and Pulmonary Mechanics in Moderate-to-severe ARDS

Role: lead

NCT06042816Not ApplicableCompleted

Analgesic Efficacy of Free-opioid Anesthesia for Colorectal Surgery

Role: lead

NCT05937113Phase 4Completed

Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

Role: lead

NCT04384016Phase 4Completed

Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old

Role: lead

NCT04695717Phase 3Completed

This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam

Role: lead

NCT04546932Not ApplicableCompleted

Lung-protective Mechanical Ventilation for Abdominal Laparoscopic Surgeries

Role: lead

NCT03713359Phase 3Completed

Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)

Role: collaborator

All 7 trials loaded